FRM
Fox Run Management’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $720K | Sell |
18,763
-17,021
| -48% | -$654K | 0.12% | 315 |
|
|
2025
Q1 | $1.39M | Buy |
+35,784
| New | +$1.39M | 0.21% | 96 |
|
|
2024
Q4 | – | Sell |
-17,073
| Closed | -$698K | – | 992 |
|
|
2024
Q3 | $698K | Sell |
17,073
-20,950
| -55% | -$856K | 0.16% | 234 |
|
|
2024
Q2 | $1.46M | Buy |
38,023
+31,733
| +504% | +$1.22M | 0.28% | 71 |
|
|
2024
Q1 | $270K | Sell |
6,290
-27,134
| -81% | -$1.16M | 0.06% | 562 |
|
|
2023
Q4 | $1.24M | Buy |
33,424
+22,444
| +204% | +$832K | 0.32% | 42 |
|
|
2023
Q3 | $398K | Buy |
+10,980
| New | +$398K | 0.12% | 344 |
|
|
2022
Q3 | – | Sell |
-7,486
| Closed | -$326K | – | 699 |
|
|
2022
Q2 | $326K | Buy |
+7,486
| New | +$326K | 0.16% | 260 |
|
|
2022
Q1 | – | Sell |
-10,628
| Closed | -$469K | – | 588 |
|
|
2021
Q4 | $469K | Buy |
+10,628
| New | +$469K | 0.28% | 96 |
|
|
2021
Q3 | – | Sell |
-6,944
| Closed | -$277K | – | 535 |
|
|
2021
Q2 | $277K | Buy |
+6,944
| New | +$277K | 0.25% | 193 |
|
|
2021
Q1 | – | Sell |
-8,417
| Closed | -$310K | – | 255 |
|
|
2020
Q4 | $310K | Buy |
+8,417
| New | +$310K | 0.63% | 43 |
|
|
2019
Q4 | – | Sell |
-8,563
| Closed | -$365K | – | 446 |
|
|
2019
Q3 | $365K | Buy |
+8,563
| New | +$365K | 0.33% | 100 |
|
|
2018
Q3 | – | Sell |
-5,235
| Closed | -$211K | – | 671 |
|
|
2018
Q2 | $211K | Sell |
5,235
-7
| -0.1% | -$282 | 0.07% | 568 |
|
|
2018
Q1 | $205K | Sell |
5,242
-2,147
| -29% | -$84K | 0.05% | 624 |
|
|
2017
Q4 | $262K | Buy |
+7,389
| New | +$262K | 0.08% | 503 |
|
|
2017
Q2 | – | Sell |
-15,400
| Closed | -$649K | – | 700 |
|
|
2017
Q1 | $649K | Buy |
+15,400
| New | +$649K | 0.26% | 103 |
|
|
2016
Q3 | – | Sell |
-9,100
| Closed | -$394K | – | 562 |
|
|
2016
Q2 | $394K | Buy |
+9,100
| New | +$394K | 0.19% | 190 |
|